(Q33971030)

30 July 2017

1 reference

title

The CD4(+) T cell response to HIV-1. (English)

1 reference

30 July 2017

Picker LJ

1

1 reference

PubMed ID

10899031

30 July 2017

Maino VC

series ordinal

2

1 reference

30 July 2017

1 August 2000

1 reference

Current Opinion in Immunology

30 July 2017

1 reference

30 July 2017

12

1 reference

30 July 2017

4

1 reference

30 July 2017

381-386

1 reference

Can the immune response control HIV infection?

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Progress in the development of an HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Human immunodeficiency virus type 1 subtypes differ in disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

HIV-induced immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Enhancement of HIV type 1 antigen-specific CD4+ T cell memory in subjects with chronic HIV type 1 infection receiving an HIV type 1 immunogen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

T cell therapy of human CMV and EBV infection in immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900104-7

7 January 2021

10.1016/S0952-7915(00)00104-7

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10899031